Zinan Yi

6PUBLICATIONS
4CO-AUTHORS
Economic development policyPreventative health carePolitical economy and social changeMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 19, 2026
Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis.

|Feb 18, 2026
Delta price cost-effectiveness analysis of PCV21 vs PCV20 use in adults aged ≥65 years in Switzerland.

Muloongo Simuzingili, Andrea Favre-Bulle, Thomas Mutschler

|Dec 10, 2025
Estimating the Health and Economic Burden of Pneumococcal Diseases Attributable to PCV21 Versus PCV20 or PPSV23 Serotypes Among Adults in Norway.

Zinan Yi, Athar Ali Tajik, Søren Toksvig Klitkou

|Apr 24, 2025
Economic evaluation of PCV21 in vaccine-naïve adults aged 19-64 years with underlying medical conditions in the United States.

Zinan Yi, Elamin H Elbasha, Kwame Owusu-Edusei

|Nov 08, 2024
Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States.

Zinan Yi, Kwame Owusu-Edusei, Elamin Elbasha

|May 25, 2024
Lifetime Health and Economic Burden of Invasive Pneumococcal Diseases Attributable to V116 Serotypes Among Adults in the United States.

Zinan Yi, Kelly D Johnson, Kwame Owusu-Edusei

Pageof 1

Frequent Collaborators

2 joint publications

Kwame Owusu-Edusei

1 joint publications

Elamin H Elbasha

1 joint publications

Andrea Favre-Bulle

1 joint publications

Eleana Tsoumani